AMG:ETR
Amgen Inc
€ 389.35
arrow_upward
+0.53%(+2.05) Siku 1
21 Okt, 13:17:44 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMG...
Fungua
€ 384.00
Juu
€ 389.35
Chini
€ 380.65
Mtaji wa soko
237.31B
Wastani wa kiasi cha mauzo
580.00
Kiasi cha mauzo ya hisa
224.00
Juu kwa wiki 52
€ 392.85
Chini kwa wiki 52
€ 247.65
Idadi ya wafanyakazi
elfu 32
Fungua
€ 384.00
Juu
€ 389.35
Chini
€ 380.65
Mtaji wa soko
237.31B
Wastani wa kiasi cha mauzo
580.00
Kiasi cha mauzo ya hisa
224.00
Juu kwa wiki 52
€ 392.85
Chini kwa wiki 52
€ 247.65
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
MarketBeat
·
saa 2 zilizopita
Amgen Inc. $AMGN Stock Holdings Raised by Robeco Institutional Asset Management B.V.
The Motley Fool
·
saa 13 zilizopita
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
GuruFocus
·
saa 15 zilizopita
Amgen Inc (AMGN) Shares Surge 3.3% -- What GF Score of 85 Tells Investors
Traders Union
·
saa 16 zilizopita
Amgen stock climbs while resistance at $447.12 approaches
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
Sekta-
Tovutiamgen.com